Radcliffe Capital Management’s SAB Biotherapeutics, Inc. Warrant SABSW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-38,927
| Closed | -$27K | – | 900 |
|
|
2022
Q3 | $27K | Sell |
38,927
-16,765
| -30% | -$11.6K | ﹤0.01% | 1185 |
|
|
2022
Q2 | $81K | Hold |
55,692
| – | – | ﹤0.01% | 1233 |
|
|
2022
Q1 | $562K | Sell |
55,692
-25,205
| -31% | -$254K | 0.01% | 1098 |
|
|
2021
Q4 | $632K | Sell |
80,897
-92,951
| -53% | -$726K | 0.02% | 947 |
|
|
2021
Q3 | $1.75M | Sell |
173,848
-1,152
| -0.7% | -$11.6K | 0.05% | 516 |
|
|
2021
Q2 | $1.74M | Hold |
175,000
| – | – | 0.05% | 548 |
|
|
2021
Q1 | $1.72M | Buy |
+175,000
| New | +$1.72M | 0.07% | 474 |
|